JSPR
Jasper Therapeutics Inc
0.5702$
+1.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | -543.5% | -339.4% | – | – | – | |
| – | – | 6.1% | 9.7% | – | – | – | |
| – | – | 16.9% | 30.3% | – | – | – | |
| – | – | 8.8% | -65.4% | – | – | – | |
| – | – | -21.3% | -4.8% | – | – | – | |
| – | – | 39.2% | 4.3% | – | – | – | |
| – | – | -39.2% | -4.3% | – | – | – | |
| – | – | 92.0% | 0.2% | – | – | – | |
| – | – | – | 0.5% | – | – | – | |
| – | – | 1,629.6% | 0.4% | – | – | – | |
| – | – | 1,046.9% | -343.8% | – | – | – | |
| – | – | -582.7% | -343.7% | – | – | – |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.